Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5303]

MYC inhibition halts metastatic breast cancer progression by blocking tumour growth, invasion & seeding

MYC inhibition halts metastatic breast cancer progression by blocking tumour growth, invasion & seeding

Three-drug combination prolongs survival in men with metastatic, hormone-sensitive prostate cancer

Three-drug combination prolongs survival in men with metastatic, hormone-sensitive prostate cancer

Alterations of the protein assembly chain discovered in cancer for the first time

Alterations of the protein assembly chain discovered in cancer for the first time

Defeating leukaemia cells by depriving them of energy

Defeating leukaemia cells by depriving them of energy

Three-drug combination prolongs survival in men with metastatic, hormone-sensitive prostate cancer

Three-drug combination prolongs survival in men with metastatic, hormone-sensitive prostate cancer

ecancer are launching a new initiative to improve cancer care in low-income countries with support from Bristol Myers Squibb

ecancer are launching a new initiative to improve cancer care in low-income countries with support from Bristol...

Improving head and neck cancer treatment

Improving head and neck cancer treatment

Sotorasib shows promise for patients with certain advanced pancreatic cancer

Sotorasib shows promise for patients with certain advanced pancreatic cancer

ASCO GU 2022: Olaparib plus abiraterone reduced risk of disease progression by 34% vs. standard-of-care in 1st-line metastatic castration-resistant prostate cancer

ASCO GU 2022: Olaparib plus abiraterone reduced risk of disease progression by 34% vs. standard-of-care in 1st...

ASCO GU: MRI-guided radiotherapy appears to lead to fewer side effects from treatment for prostate cancer

ASCO GU: MRI-guided radiotherapy appears to lead to fewer side effects from treatment for prostate cancer

More from ecancer